At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
00867 CMS
Market Closed 07-03 16:08:15
11.530
+0.280
+2.49%
High11.710Low11.250Vol8.73M
Open11.320D1 Closing11.250Amplitude4.09%
Mkt Cap28.05BTradable Cap28.05BTotal Shares2.43B
T/O100.43MT/O Rate0.36%Tradable Shares2.43B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
CMS Repurchases 5.38 Million Shares in June, Outstanding Share Count Trimmed to 2.43 Billion
Bulletin Express  ·  07-02 17:33
CMS Repurchases 5.38 Million Shares in June, Outstanding Share Count Trimmed to 2.43 Billion
China Medical System Files Board, Board Committee and Management Disclosure Roster
Reuters  ·  06-29
China Medical System Files Board, Board Committee and Management Disclosure Roster
CMS Appoints Li Xianliang as Independent Non-Executive Director
Stock News  ·  06-29
CMS Appoints Li Xianliang as Independent Non-Executive Director
CMS repurchases 0.50 million shares for HK$5.06 million; treasury stock rises to 6.40 million shares
Bulletin Express  ·  06-24
CMS repurchases 0.50 million shares for HK$5.06 million; treasury stock rises to 6.40 million shares
How NMPA Approval of First-in-Class Rabies Antibody Will Impact China Medical System (SEHK:867) Investors
Simply Wall St.  ·  06-22
How NMPA Approval of First-in-Class Rabies Antibody Will Impact China Medical System (SEHK:867) Investors
China Medical System Gets China Nod for Rabies Drug Application
MT Newswires  ·  06-22
China Medical System Gets China Nod for Rabies Drug Application
CMS Secures Chinese NDA Approval for Novel Anti-Rabies Bispecific Antibody Sileweimimab
Stock News  ·  06-22
CMS Secures Chinese NDA Approval for Novel Anti-Rabies Bispecific Antibody Sileweimimab
China Medical System says China approves rabies antibody drug Silevimig Injection
Reuters  ·  06-22
China Medical System says China approves rabies antibody drug Silevimig Injection
China Medical System - Silevimig Injection Approved by China Nmpa on 22 June 2026
THOMSON REUTERS  ·  06-22
China Medical System - Silevimig Injection Approved by China Nmpa on 22 June 2026
China Medical System Holdings (SEHK:867) Stock Could Be Below Fair Value After CMS D008 Update
Simply Wall St.  ·  06-20
China Medical System Holdings (SEHK:867) Stock Could Be Below Fair Value After CMS D008 Update
CMS Buys Back 400,000 Shares for HKD 4.11 Million, Issued Share Count Trimmed to 2.43 Billion
Bulletin Express  ·  06-17
CMS Buys Back 400,000 Shares for HKD 4.11 Million, Issued Share Count Trimmed to 2.43 Billion
CMS Executes Share Buyback, Spending HK$4.11 Million
Stock News  ·  06-17
CMS Executes Share Buyback, Spending HK$4.11 Million
China Medical System files HKEX next-day disclosure return reporting share repurchase
Reuters  ·  06-17
China Medical System files HKEX next-day disclosure return reporting share repurchase
How Investors Are Reacting To China Medical System (SEHK:867) Advancing Its siRNA-Based Obesity Pipeline
Simply Wall St.  ·  06-15
How Investors Are Reacting To China Medical System (SEHK:867) Advancing Its siRNA-Based Obesity Pipeline
CMS Repurchases 400,000 Shares, Raising Treasury Stock to 5.50 Million
Bulletin Express  ·  06-09
CMS Repurchases 400,000 Shares, Raising Treasury Stock to 5.50 Million
CMS Repurchases 1.01 Million Shares for HK$10.44 Million, Lifting Treasury Stock to 5.10 Million
Bulletin Express  ·  06-08
CMS Repurchases 1.01 Million Shares for HK$10.44 Million, Lifting Treasury Stock to 5.10 Million
CMS Conducts Share Buyback, Spending HK$10.44 Million on June 8
Stock News  ·  06-08
CMS Conducts Share Buyback, Spending HK$10.44 Million on June 8
China Medical System files HKEX next-day disclosure return reporting share buyback at HKD 10.33 each
Reuters  ·  06-08
China Medical System files HKEX next-day disclosure return reporting share buyback at HKD 10.33 each
China Medical System files HKEX next-day return disclosing share buyback at HKD 10.55 each
Reuters  ·  06-04
China Medical System files HKEX next-day return disclosing share buyback at HKD 10.55 each
CMS Executes Share Buyback Valued at HK$9.69 Million on June 3
Stock News  ·  06-03
CMS Executes Share Buyback Valued at HK$9.69 Million on June 3

Introduction

Company Name.
CMS
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and sales of drugs. The Company's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The Company distributes its products within domestic market and to overseas markets.
Issue price:
--